Connect Biopharma Holdings (CNTB) revenue and earnings history
Connect Biopharma Holdings reported revenue of $64K for fiscal 2025 (year ended Dec 31, 2025), −99.8% on the year before, and net income of −$55.5M.
Revenue and net income, 3 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $64K−99.8% | −$58.1M | −$55.5M | −$51.2M | $434K | −$51.6M | $3.73M | — | — | $38.3M | — | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Connect Biopharma Holdings (CNTB) on OQRO.
Common questions
What was Connect Biopharma Holdings's revenue in fiscal 2025?
$64K for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 31, 2026. That is −99.8% on fiscal 2024 ($26M).
Has Connect Biopharma Holdings been profitable?
It reported a net loss in 3 of the years shown (2023, 2024, 2025). The highest net income was −$15.6M in fiscal 2024.
What was Connect Biopharma Holdings's free cash flow in fiscal 2025?
−$51.6M: operating cash flow of −$51.2M minus capital expenditure of $434K. OQRO calculates free cash flow this way from the two filed lines.
Why is earnings per share not in this table?
Where these figures come from
The SEC’s companyfacts data: every figure Connect Biopharma Holdings tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
